Women Enrollment In Phase I/II Trials Continues To Be Low, GAO Says
Women continue to be under-represented in early phase safety studies, a General Accounting Office report on women in clinical trials suggests.
Women continue to be under-represented in early phase safety studies, a General Accounting Office report on women in clinical trials suggests.